Sarah Challenor
2PUBLICATIONS
7CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Jan 12, 2022
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL.Michael Northend, William Wilson, Wendy Osborne
Pageof 1

